Nation’s First Angioedema Treatment Center Is at UC San Diego

US Hereditary Angioedema Association and four corporate partners endow center to treat rare hereditary swelling disease —

It is rare for an “orphan” disease (typically a condition that affects fewer than 200,000 people nationwide) to have a specific center dedicated to providing treatment and research. And it is even more unusual for big pharmaceutical companies to invest in an endowment to fund this type of center. Fortunately, the US Hereditary Angioedema Association (HAEA), a nonprofit patient advocacy organization, along with four pharmaceutical companies—Shire Human Genetics Therapies Inc., ViroPharma Incorporated (which merged with Shire), Dyax Corp. and CSL Bering—pledged a total of $4.6 million to help make the US HAEA Angioedema Center at UC San Diego Health System a reality. A number of individuals, including those with the disease, also provided private support. … Read the full story from the UC San Diego News Center


Dr. Bruce Zuraw

Dr. Bruce Zuraw

Dr. Bruce Zuraw is director of the US HAEA Angioedema Center at UC San Diego Health System and inaugural recipient of the US HAEA Endowed Chair at UC San Diego. He is professor of medicine and chief of the Division of Rheumatology, Allergy & Immunology.

Dr. Marc Riedl

Dr. Marc Riedl

Marc Riedl, MD, MS, associate professor of medicine, is clinical director of the center.

 

First Angioedema Treatment Center Opens at UC San Diego Health System

UC San Diego Health System in partnership with the U.S. Hereditary Angioedema Association (HAEA), a non-profit patient advocacy organization, has opened the nation’s first dedicated center for diagnosing and treating diverse forms of swelling, known collectively as angioedema.

The U.S. HAEA Angioedema Center at UC San Diego Health System will serve as an international referral center for people with all types of angioedema and will work closely with basic science laboratories at UC San Diego School of Medicine to better understand the condition and develop new treatments. … Read the full story from the UC San Diego Newsroom


Dr. Bruce Zuraw

Dr. Bruce Zuraw

Bruce Zuraw, MD, professor of medicine and chief of the Division of Rheumatology, Allergy and Immunology, is the U.S. HAEA Angioedema Center’s director and the inaugural recipient of the U.S. HAEA Endowed Chair at UC San Diego.  |  Dr. Zuraw’s clinical profile

Dr. Marc Riedl

Dr. Marc Riedl

Marc Riedl, MD, MS, associate professor of medicine, is the Center’s clinical director.  |  Dr, Riedl’s clinical profile

 

Bruce Zuraw, MD, Is New Chief of Rheumatology, Allergy & Immunology Division

Announcement

From Wolfgang H. Dillmann, MD
Helen M. Ranney Distinguished Professor
Chair of the Department of Medicine

I am pleased to announce that an internal review committee has selected Dr. Bruce Zuraw as the new chief of the Division of Rheumatology, Allergy & Immunology in the Department of Medicine. He is also inaugural holder of the US Hereditary Angioedema Association (HAEA) Endowed Chair.

I would like to express my gratitude to Dr. Robert Terkeltaub, who accepted the role of interim division chief after Dr. Gary Firestein stepped down in June 2010. In leading the Division of Rheumatology, Allergy & Immunology for the past three years, Dr. Terkeltaub has done an important service for the division and the department.

Bruce L. Zuraw, MD, professor of medicine, is Director of the Section of Allergy and Immunology at the Veterans Affairs San Diego Healthcare System and head of the Allergy & Immunology section of the Division of Rheumatology, Allergy & Immunology at UC San Diego. He directs the Allergy and Immunology Fellowship Program.

Dr. Zuraw is a highly respected clinician, researcher and thought leader in the field of allergy and immunology and an internationally recognized expert in hereditary angioedema. He chairs the Medical Advisory Board of the US Hereditary Angioedema Association (HAEA) and will direct the newly established US HAEA Angioedema Center at UC San Diego.

Dr. Zuraw joined the faculty of the UC San Diego School of Medicine in 2004 after many years as a fellow, clinician, researcher and leader at Scripps Clinic & Research Foundation and The Scripps Research Institute.

He was born in Brookline, Massachusetts, and received his undergraduate degree in biology from Carleton College in Northfield, Minnesota, in 1972. He earned his M.D. degree and completed his internal medicine residency training at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois.

Dr. Zuraw received his fellowship training and established his research and clinical career in allergy and immunology at Scripps Clinic and Research Foundation and The Scripps Research Institute in La Jolla. There, he rose to the rank of associate professor in the Department of Molecular and Experimental Medicine and held a number of leadership positions, including director of the Allergy & Immunology Fellowship Training Program, associate director of the General Clinical Research Center and director of research for the Scripps Internal Medicine Residency Program.

Dr. Zuraw has been very active in service to the University and the Veterans Affairs San Diego Healthcare System. In addition to his divisional and educational program leadership positions, he has chaired the VA Research Space Committee and served on the DOMCAP Committee. He is currently on the VA Research Information Security Subcommittee and the Intern Selection Committee of the UCSD Internal Medicine Residency Program.

In his research, Dr. Zuraw is a highly respected investigator in the area of allergic inflammation in humans, with particular attention to hereditary angioedema, and the mechanism of action of glucocorticoids. He is principal investigator of a number of basic and clinical research projects including major projects funded by the National Institutes of Health, the Department of Defense, and the VA Merit program. He has published more than 120 peer-reviewed articles and nearly 50 invited reviews and book chapters.

Please join me in giving your enthusiastic support to Dr. Bruce Zuraw in his new position of leadership in the Department of Medicine.